Physiological, Hormonal, and DNA-based Mechanisms of Psychosocial Stress and Therapeutic Effect
- Conditions
- Well-Being, Psychological
- Registration Number
- NCT07152652
- Lead Sponsor
- University of Helsinki
- Brief Summary
The goal of this trial is to learn if the Groups 4 Health (G4H) intervention is effective in supporting student well-being at the University of Helsinki. It will also learn about the factors that may influence the efficacy of the intervention (such as facilitators characteristics, stress physiology and changes in gene expression). The main questions it aims to answer are:
1. Is the G4H intervention effective and cost-effective in supporting student well-being?
2. To what extent participants' physiological, hormonal, or molecular characteristics mediate the therapeutic effect of the G4H
3. To what extent participants' genotype moderates the effect of the G4H
4. To what extent facilitators' characteristics mediate or moderate the effect of the G4H
Data is collected from both the intervention participants and the facilitators.
The G4H facilitators will:
* Facilitate the G4H intervention.
* Fill in questionnaires and provide physiological and molecular measurements before, during, and after the G4H intervention.
The G4H participants will:
* Participate in the G4H intervention.
* Fill in questionnaires and provide physiological, hormonal and molecular measurements before, during, and after the G4H intervention.
- Detailed Description
This study is a randomized waitlist-controlled trial for investigating the efficacy and cost-efficacy of Groups 4 Health (G4H) brief psychosocial intervention for loneliness among the students at the University of Helsinki. Furthermore, several biological and psychosocial mechanisms that may exert the effects of psychosocial stress and therapeutic change are studied. In addition to various psychosocial factors, the mechanisms include genetic factors and epigenetic alterations, hypothalamic-pituitary axis (HPA) activity (cortisol), and parasympathetic (HRV) and sympathetic (alpha amylase) function of the autonomic nervous system (ANS).
This trial will investigate:
1. The efficacy and cost-efficacy of the G4H in a wait-list controlled RCT
2. To what extent participants' physiological, hormonal or molecular measures of ANS, cortisol, alpha amylase, and DNAm mediate the therapeutic effect of the G4H.
3. To what extent participants' genotype moderates the effects of the G4H.
4. To what extent facilitators' characteristics mediates or moderates the effect of the G4H.
The participants will be randomized to start the G4H immediately after randomization or after the waitlist-period of 19 weeks (7 weeks active G4H + 3 months follow-up). The G4H includes five facilitated group sessions and will be delivered over a 7-week period. Data is collected before, during, and after the intervention, as well as in 1-, 3-, and 12-month follow-ups. The wait-list control group does not provide 12-months follow-up data, as they receive the intervention after the 19 weeks waitlist-period.
METHODS:
The study's outcome measures are described in the outcome measures -section. In addition, the following measures are used to answer the research questions.
Experience Sampling Method (ESM):
ESM is used to measure frequent, real-time assessments of participants self-reported mood, and stress appraisals at multiple times throughout the day. ESM is applied to explore the variation and changes in participants daily subjective well-being and loneliness in concurrence with G4H group facilitators stress appraisals before and after facilitation of G4H sessions. The ESM data will be collected using GDPR compliant experience-sampling software program that runs on smartphones (e.g. m-Path).
The daily ESM protocol consists of a morning and evening prompts in which participants are asked to rate their momentarily affect, and daily satisfaction with life. In the morning prompt, participants are also asked to assess daily physiological correlates such as sleep, amount of caffeine, and alcohol consumption, and exercise during the last 24h.
Intervention participants are also asked to answer questions about momentarily appraisal of social company, and loneliness (see outcome measures). Facilitators' event-based sampling takes place before and after the group facilitation and consists of self-report on the appraisals and experiences related to situation with single items derived from widely used questionnaires.
Experiences related to the pre-group situation are assessed from the facilitators during the intervention with items related to momentarily affect: "When thinking about the upcoming group session I feel: calm; happy; determined; enthusiastic; tired; stressed; worried; anxious" (response options: 0 =not at all - 6 = very much), and expectations: "I have prepared well for the session; I trust in my ability to manage the upcoming group session; I expect the session to go well." (response options: 0 = strongly disagree - 6 = strongly agree). Experiences related to the post-group situation are assessed with items related to the group situation: "I feel that the group session went well; I felt competent in facilitating the session; I was present during the session; It was easy for me to feel compassion towards participants" (response options: 0 = strongly disagree - 6 = strongly agree).
Salivary cortisol and alpha amylase:
Saliva samples with Cortisol Salivette synthetic swabs (Sarsted) are collected for cortisol and alpha-amylase measurements from both the intervention participants (see outcomes) and facilitators. These samples are collected by placing a synthetic swab in mouth for 2 minutes and returning it to a plastic tube thereafter.
The cortisol and alpha-amylase samples are provided by the participating facilitators during the first, third, and last intervention sessions. The sampling times are -45, -10, 45, 90, 110, and 135 minutes from the start of the session (6 samples per session).
Covariates related to the stress measurements:
Information on the following potential covariates related to stress physiology is also collected from the intervention participants and facilitators on the same day as the saliva samples are given: situational stress, sleep, physical activity, smoking, alcohol and coffee consumption, menstrual cycle, medication, chronic illness.
DNA measures:
Omnigene saliva Oragene OG-600 DNA (or equivalent) is used for the DNAm and genotype sampling. Both the intervention participants and the facilitators will provide these samples before and immediately after the intervention.
Autonomic nervous system functioning:
A self-developed bra-integrated solution is used to collect non-medical electrocardiogram (ECG)-signal and accelometer data from the facilitators. Data is collected by wearing a bra during times, when user regularly would use it, but especially on days when there is activity of G4H study. ECG signal is analysed by time- and frequency-based Hearth rate variability analysis (HRV). Accelometer data is used to estimate physical activity and used for control high movement effects on HRV. HRV is used to assess daily levels of sympathetic and parasympathetic function of the ANS and to estimate cognitive load effects of facilitating G4H sessions.
Participants' background:
Participants' background information is collected from the intervention participants as potential covariates: gender, birth date, mother tongue, marital status, household composition, residential situation, employment status, education, income, subjective financial situation, subjective health, subjective loneliness, subjective minority status and willingness to participate in the intervention and academic skills (4-item organized studying scale, from Learn -questionnaire).
Facilitators' characteristics:
Information is collected at pre-intervention on the facilitator's background (gender, birth date, marital status, household composition, residential situation, employment status, education, work experience, income, subjective financial situation), and professional (12-item Experiences in Close Relationships Short form) and individual (30-item Extra-Short Five -questionnaire) characteristics.
The facilitators will also answer questionnaires during the intervention on study burnout risk (9-item Study Burnout Inventory, at pre-intervention and last session), perceived stress (10-item Perceived Stress Scale, at pre-intervention, 3rd, and last session), self and other compassion (4-item Process Based Assessment Tool, at pre-intervention, 3rd, and last session), and self-assessed skillfulness, difficulties, and feelings (36-item Therapist Work Involvement Scales, at 3rd and last session) as potential mediators or moderators of the intervention's effectiveness.
SAMPLE SIZE AND ANALYSES:
The minimum sample size is 148 intervention participants. Appropriate statistical methods including linear mixed model analyses will be used to study the effectiveness of the G4H intervention and the mediating and moderating factors. Appropriate imputation methods such as multiple imputation by chained equations will be used if necessary.
Written informed consent is gathered from all participants. The participants who have given their consent have the option to withdraw from the study at any point.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 148
- Adult (age 18 and above)
- Student in the University of Helsinki, Finland
- Able to speak/read Finnish, Swedish, or English
- None
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Loneliness 1) Before the intervention, 2) During the intervention (week 3), 3) immediately after the intervention, 4) one month follow-up, 5) three months follow-up, 6) 12 months follow-up Loneliness is measured with the 4 and 8-item short forms of the revised University of California, Los Angeles Loneliness Scale (ULS-4 and ULS-8, response options: 1=never, 2=rarely, 3=sometimes, 4=often, lower score means better outcome).
Depression 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up Symptoms of depression are assessed with the 9-item Patient Health Questionnaire (response options: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day, lower score means better outcome).
Active group memberships 1) Before the intervention, 2) During the intervention (week 3), 3) immediately after the intervention, 4) one month follow-up, 5) three months follow-up, 6) 12-months follow-up Multiple group memberships are assessed with the 4-item Exeter Identity Transition Scale (response options: 1 = strongly disagree, 7 = strongly agree, higher score means better outcome).
Mental well-being 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up Mental well-being is assessed with the 7-item Short Warwick-Edinburgh Mental Wellbeing Scale (response options: 1=not at all, 2=rarely, 3=occasionally, 4=often, 5=all the time, higher score means better outcome).
General well-being 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up General well-being is assessed with the 14-item General Population version of the Clinical Outcomes in Routine Evaluation (response options: 0=not at all, 1=only occasionally, 2=sometimes, 3=often, 4=most of/all of the time, lower score means better outcome).
Anxiety 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up Symptoms of anxiety are assessed with the 7-item Generalized Anxiety Disorder Questionnaire (response options: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day, lower score means better outcome).
Social anxiety 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up Social anxiety is assessed with the 3-item Mini Social Phobia Inventory (response options: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day, lower score means better outcome).
- Secondary Outcome Measures
Name Time Method Perceived Stress 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up Perceived stress is measured with the 10-item Perceived Stress Scale (response options: 0 = never, 1 = almost never, 2=sometimes, 3=fairly often, 4=very often, lower scores means better outcome)
Self- and other-compassion 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up Self- and other-compassion is measured with the 4-item Process Based Assessment Tool (response options: 1=very seldom to 5=very often, higher scores means better outcome)
Health-related quality of life 1) Before the intervention, 2) immediately after the intervention, 3) three months follow-up Health-related quality of life is measured with the Euro Quality of Life - 5 dimension - 5 level questionnaire (EQ-5D-5L). The measure has 5 dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) comprising of five statements of which the respondent can choose the option that best describes their situation. Higher score means better outcome. This measure is used to calculate the cost-effectiveness of the interventions.
Use of social and health care services 1) Before the intervention, 2) immediately after the intervention, 3) three months follow-up The use of social and health care services for mental health is measured with a self-report questionnaire (medications, health care appointments, hospitalization, counseling). The use of health care services will be monetarized by using Finnish national unit costs. This measure is used to calculate the cost-effectiveness of the interventions.
Time used by facilitators Immediately after each intervention session, during 8 weeks The time used for planning, executing, and assessing the G4H sessions is reported by the facilitators. This measure is used to calculate the cost-effectiveness of the interventions.
Study credits 1 year before the intervention, 1 year after the intervention Overall accumulated study credit data is gathered from the UH registries. These data will be used both as measures of effectiveness of the interventions and to account for the confounders in the statistical analyses.
Grade point average 1 year before the intervention, 1 year after the intervention One year grade point average is gathered from the UH registries. These data will be used both as measures of effectiveness of the interventions and to account for the confounders in the statistical analyses.
Weighted grade point average 1 year before the intervention, 1 year after the intervention Weighted grade point average is determined by the grades of each course weighted by the number of credits gained for it.
Study burnout risk 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up Study burnout risk is measured by the 9-item Study Burnout Inventory (response options: 1=Completely disagree, 2=Disagree, 3=Partly disagree, 4=Partly agree, 5=Agree, 6=Completely agree. Lower score means better outcome).
Sleep quality 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up Sleep quality is measured with the Single-Item Sleep Quality Scale (response options: 0=terrible to 10=excellent, higher score means better outcome)
Salivary cortisol The participants provide the samples on two consecutive days 1) before the intervention 2) after the intervention, and 3) at 3-months follow-up. The sampling times are 0, 30, 45, and 60 minutes after awakening (4 samples per day). The cortisol awakening profile is used as an index of hypothalamic-pituitary-adrenal axis function reflecting stress physiology. The participants' salivary cortisol profiles are studied relative to awakening times. Atypical awakening profiles indicate poorer outcome.
Salivary alpha-amylase The participants provide the samples on two consecutive days 1) before the intervention 2) after the intervention, and 3) at 3-months follow-up. The sampling times are 0, 30, 45, and 60 minutes after awakening (4 samples per day). The alpha amylase awake The salivary alpha-amylase is used as an index of sympathetic nervous system function reflecting stress physiology. The participants' salivary alpha amylase profiles are studied relative to awakening times. Atypical awakening profiles indicate poorer outcome.
Daily positive and negative affect 1) Before the intervention, 2) During the intervention, 3) immediately after the intervention, 4) three months follow-up] Daily affect is assessed with items of The Positive and Negative Affect Schedule: "To what extent do you currently feel: calm; happy; enthusiastic; tired; stressed; anxious?" (response options: 0 =not at all - 6 = very much).
Daily health-related information 1) Before the intervention, 2) During the intervention, 3) immediately after the intervention, 4) three months follow-up Daily health-related factors are assessed with items adapted from the Finnish Institute of Occupational Health Sleep and Health Information Form. Perceived sleep quality and quantity is assessed with an item "Last night I slept well/ enough". (response options: 0 = strongly disagree - 6 = strongly agree). Use of caffeine, alcohol and nicotine products, and amount of physical activity during the past 24 hours are assessed by reporting usage (yes/ no) or the amounts.
Daily momentary loneliness 1) Before the intervention, 2) During the intervention, 3) immediately after the intervention, 4) three months follow-up Daily momentary loneliness, and appraisals related to company are assessed with items "I feel lonely" (response options: 0 =not at all - 6 = very much), and if in company "I enjoy this company" (response options: 0 = strongly disagree - 6 = strongly agree).
Daily satisfaction with life 1) Before the intervention, 2) During the intervention, 3) immediately after the intervention, 4) three months follow-up Daily life satisfaction is measured with an item: "How satisfied were you with your life today?" (response options: 0 = not at all satisfied - 6 = very satisfied).
Trial Locations
- Locations (1)
University of Helsinki
🇫🇮Helsinki, Uusimaa, Finland
University of Helsinki🇫🇮Helsinki, Uusimaa, FinlandJari Lahti, PhDContact040 571 2297jari.lahti@helsinki.fi